Picture of Rapid Micro Biosystems logo

RPID — Rapid Micro Biosystems News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSucker Stock

Rapid Micro Biosystems Inc expected to post a loss of 31 cents a share - Earnings Preview

* Rapid Micro Biosystems Inc  RPID.OQ   RPID.O  is expected
to show a rise in quarterly revenue when it reports  results 
    * The Lowell Massachusetts-based  company is expected to
report  a
17.1% increase in revenue to $5.55 million from $4.74 million a
year ago, according to the mean estimate from 2 analysts, based
on LSEG data. 
    * ​Refinitiv's mean analyst estimate for Rapid Micro
Biosystems
Inc is for a loss of 31 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Rapid Micro
Biosystems Inc is $5.88​, above​ its last closing price
of $1.03. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.35       -0.35      -0.33     Beat    5.7
 Mar. 31 2023  -0.37       -0.36      -0.32     Beat    12.3
 Dec. 31 2022  -0.34       -0.36      -0.39     Missed  -8.3​
 Sep. 30 2022  -0.37       -0.37      -0.38     Missed  -3.6
 ​​Jun.        -0.33       -0.32      -0.31     Beat    2.4
 30 2022                                                
 Mar. 31 2022  -0.34       -0.33      -0.35     Missed  -4.5​
 Dec. 31 2021  -0.24       -0.28      -0.35     Missed  -25
 Sep. 30 2021  -0.38       -0.38      -0.63     Missed  -67.3
 This summary was machine generated November 1 at 19:32 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Rapid Micro Biosystems

See all news